Clinical Trial Update: A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer [Phase 2]

View source ↗

Summary

Phase II randomized trial comparing EOX (epirubicin, oxaliplatin, capecitabine) versus ElTax (docetaxel, oxaliplatin) in advanced gastroesophageal cancer has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)
• Epirubicin (epirubicin)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Gastro Oesophageal Cancer | Phase 2 | Status: COMPLETED